Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Herz|November 2, 2014
[Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?]A K Gitt, R ZahnHeart (British Cardiac Society)|April 12, 2006
Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practiceT Heer, U Zeymer, C Juenger, et al.American Heart Journal|February 15, 2001
Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studiesB Frilling, R Schiele, A K Gitt, et al.The American Journal of Cardiology|January 4, 2001
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction RegistryR Zahn, R Schiele, S Schneider, et al.European Heart Journal|September 11, 2001
Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR)M Gottwik, R Zahn, R Schiele, et al.Journal of the American College of Cardiology|June 13, 2001
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction RegistryR Zahn, R Schiele, S Schneider, et al.American Heart Journal|June 30, 2001
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysisR Zahn, R Schiele, A K Gitt, et al.Herz|January 6, 2001
Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)R Zahn, R Schiele, S Schneider, et al.Zeitschrift Fur Kardiologie|June 24, 2003
Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume centerR Zahn, B Fraiture, K-E Siegler, et al.Pageof 23